What is Omada Health, Inc. Common Stock's market cap?

Omada Health, Inc. Common Stock (OMDA) has a market capitalization of $1.1B and trades on NASDAQ.

What is Omada Health, Inc. Common Stock's revenue and profitability?

Omada Health, Inc. Common Stock generated $283.3M in trailing twelve-month revenue with a net loss of $20.9M, representing a net margin of -11.3%. Gross margin stands at 66.3%, with free cash flow of -$13.8M. These figures are based on the Q1 2026 filing.

Who are Omada Health, Inc. Common Stock's competitors?

Omada Health, Inc. Common Stock's key competitors include Teladoc Health, Inc., DarioHealth Corp., Viking Therapeutics, Inc, and others. These companies compete in similar markets and product categories.

What subsidiaries does Omada Health, Inc. Common Stock have?

Omada Health, Inc. Common Stock's subsidiaries include Physera Physical Therapy Group, PC.

Where is Omada Health, Inc. Common Stock headquartered?

Omada Health, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2025.

Omada Health, Inc. Common Stock

OMDA

Omada Health is a virtual-first healthcare provider that delivers long-term behavior change programs for chronic conditions including diabetes, hypertension, and musculoskeletal issues.

Market cap

$1.11B+4.0%

Revenue$283.3M+49.4%

Net income-$20.9M+55.7%

Free cash flow-$13.8M+72.4%

EPS (diluted)-$1.50+75.4%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$78.0MBeat by $4.0M EPS-$0.05Beat by $0.08

Read the full report

Next report

Aug 6, 2026 (in a month)

Revenue estimate$80.1M

EPS estimate$0.05

Financials

Q1 2026

Income statement

See full

Revenue$78.0M+42.0%

Gross profit$48.7M+52.6%

Operating income-$4.8M+43.1%

Net income-$3.0M+68.6%

EPS (diluted)-$0.05+95.7%

Balance sheet

See full

Cash & equivalents$211.8M+257%

Total equity$234.1M+160%

Total assets$302.8M—

Cash flow

See full

Operating cash flow-$11.8M+26.6%

CapEx$78.0K-75.2%

Free cash flow-$11.9M+27.5%

Valuation & ratios

Valuation

See full

Market cap$1.11B+4.0%

P/S3.9×-0.4×

Profitability

See full

Gross margin66.3%+4.4pp

Returns & leverage

See full

Current ratio3.9×—

Segments

By product

See full

Services$69.6M+40.6%

Hardware$8.5M+54.6%

By segment

See full

Reportable Segment$78.0M+42.0%

Competitors

By market cap

Eli Lilly$996.31B

Insulet$10.3B

Hinge Health, Inc.$5.5B

Viking Therapeutics$4.4B

Teladoc Health$1.4B

Omada Health, Inc. Common Stock$1.1B

Tandem Diabetes Care$1.0B

DarioHealth$44.3M

By revenue growth

Hinge Health, Inc.+49.8%

Omada Health, Inc. Common Stock+49.4%

Eli Lilly+47.4%

Insulet+31.9%

Tandem Diabetes Care+4.5%

Teladoc Health-1.5%

By net margin

Eli Lilly34.99%

Insulet10.44%

Teladoc Health-6.81%

Tandem Diabetes Care-9.2%

Omada Health, Inc. Common Stock-11.27%

Hinge Health, Inc.-83.91%

Profile

Omada Health is a virtual-first healthcare provider that delivers long-term behavior change programs for chronic conditions including diabetes, hypertension, and musculoskeletal issues. The company utilizes a human-led, technology-enabled care model called Compassionate Intelligence to provide personalized support between traditional doctor visits. Its value proposition centers on improving clinical outcomes and reducing healthcare costs for employers, health plans, and pharmacy benefit managers.

Competitive position

Omada differentiates itself through a multi-condition platform grounded in peer-reviewed clinical research and a human-led coaching model enhanced by proprietary AI.

GeographiesUnited States

Customer segmentsEnterprise Employers, Health Insurance Companies, Pharmacy Benefit Managers, Health Systems

Business modelB2B2C, Subscription SaaS, Electronic Claims Billing

SuppliersConnected device manufacturers, Cloud infrastructure providers, Third-party large language model providers, Licensed clinical specialists

CustomersSelf-insured corporations, Commercial health insurers, Government health programs, Individual health plan members

CountryUnited States of America

Listed2025

CEOSean Duffy

Websiteomadahealth.com

FilingsSEC EDGAR

Ask your AI about Omada Health, Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Omada Health, Inc. Common Stock's market cap?: Omada Health, Inc. Common Stock (OMDA) has a market capitalization of $1.1B and trades on NASDAQ.
What is Omada Health, Inc. Common Stock's revenue and profitability?: Omada Health, Inc. Common Stock generated $283.3M in trailing twelve-month revenue with a net loss of $20.9M, representing a net margin of -11.3%. Gross margin stands at 66.3%, with free cash flow of -$13.8M. These figures are based on the Q1 2026 filing.
Who are Omada Health, Inc. Common Stock's competitors?: Omada Health, Inc. Common Stock's key competitors include Teladoc Health, Inc., DarioHealth Corp., Viking Therapeutics, Inc, and others. These companies compete in similar markets and product categories.
What subsidiaries does Omada Health, Inc. Common Stock have?: Omada Health, Inc. Common Stock's subsidiaries include Physera Physical Therapy Group, PC.
Where is Omada Health, Inc. Common Stock headquartered?: Omada Health, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2025.